Shaun Patterson
@shaundavid01.bsky.social
Postdoctoral researcher focused on CML and AML. University of Glasgow based.
Our work on BCR::ABL1 in bone marrow vs. peripheral blood to predict treatment free remission in chronic myeloid leukaemia is now published in Leukemia!
Jointly authored with TU Dresden and the Hammersmith.
www.nature.com/articles/s41...
@pogresearch.bsky.social
@uofgcancersciences.bsky.social
Jointly authored with TU Dresden and the Hammersmith.
www.nature.com/articles/s41...
@pogresearch.bsky.social
@uofgcancersciences.bsky.social
Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow -...
Leukemia - Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or...
www.nature.com
January 7, 2026 at 12:29 PM
Our work on BCR::ABL1 in bone marrow vs. peripheral blood to predict treatment free remission in chronic myeloid leukaemia is now published in Leukemia!
Jointly authored with TU Dresden and the Hammersmith.
www.nature.com/articles/s41...
@pogresearch.bsky.social
@uofgcancersciences.bsky.social
Jointly authored with TU Dresden and the Hammersmith.
www.nature.com/articles/s41...
@pogresearch.bsky.social
@uofgcancersciences.bsky.social
It was great to present our abstract focusing on the predictive power of intronic variants for treatment-free remission in CML patients at @ash.hematology.org 2025. Thank you to @bscb-official.bsky.social for supporting my conference attendance this year and @cancerresearchuk.org grant funding
December 17, 2025 at 10:26 AM
It was great to present our abstract focusing on the predictive power of intronic variants for treatment-free remission in CML patients at @ash.hematology.org 2025. Thank you to @bscb-official.bsky.social for supporting my conference attendance this year and @cancerresearchuk.org grant funding
Our collaborative manuscript with TU Dresden is now available as a preprint! As a joint first author with Andrea Gottschalk, I was involved in a study combining our PCR-based evaluation of BCR::ABL1 levels with mathematical modelling approaches to predict TFR. www.medrxiv.org/content/10.1...
BCR::ABL1 evaluation in bone marrow is no more predictive of TFR success than from peripheral blood
Background: Despite the excellent survival for chronic myeloid leukaemia (CML) patients treated with tyrosine kinase inhibitors (TKI), most CML patients report poorer quality of life due to TKI side-e...
www.medrxiv.org
September 4, 2025 at 9:02 AM
Our collaborative manuscript with TU Dresden is now available as a preprint! As a joint first author with Andrea Gottschalk, I was involved in a study combining our PCR-based evaluation of BCR::ABL1 levels with mathematical modelling approaches to predict TFR. www.medrxiv.org/content/10.1...
Congratulations to Isla Nosratzadeh for presenting her excellent work on assessing mesenchymal stem cell senescence in CML patients from the DESTINY trial as a means of identifying biomarkers for treatment-free remission. She delivered an interesting and clear talk! #CML #TFR #MSCs
April 28, 2025 at 5:07 PM
🤯
January 23, 2025 at 11:04 PM
🤯
Let's encourage (x) users to move over in urgency! As a society, we cannot support these tech oligarchs' platforms. I don't want this feed to be political, but there are certain times where it is essential.
January 23, 2025 at 10:32 PM
Let's encourage (x) users to move over in urgency! As a society, we cannot support these tech oligarchs' platforms. I don't want this feed to be political, but there are certain times where it is essential.
Two potential fundraising challenges for 2025 - Staffin triathlon (I've never done one of these) or another marathon? Didn't get a place in Berlin marathon again, so I'll keep trying!
December 21, 2024 at 12:33 PM
Two potential fundraising challenges for 2025 - Staffin triathlon (I've never done one of these) or another marathon? Didn't get a place in Berlin marathon again, so I'll keep trying!
I was delighted to present our work on lymphoid populations in CML patients who aimed for TFR in the DESTINY trial. Thank you to Prof Mhairi Copland for leading this project and to the patients who donated bone marrow samples for the trial.
#ASH24 @ash-hematology.bsky.social
#ASH24 @ash-hematology.bsky.social
December 10, 2024 at 2:52 AM
I was delighted to present our work on lymphoid populations in CML patients who aimed for TFR in the DESTINY trial. Thank you to Prof Mhairi Copland for leading this project and to the patients who donated bone marrow samples for the trial.
#ASH24 @ash-hematology.bsky.social
#ASH24 @ash-hematology.bsky.social